Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial

Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:42:26.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the ongoing efficacy, safety, and tolerability study of eteplirsen in subjects with Duchenne Muscular Dystrophy. This change may reflect new data or findings related to the correlation between biomarkers for DMD and the clinical status of participating subjects.
    Difference
    0.1%
    Check dated 2024-06-06T14:32:24.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed information about eligibility criteria, including examples and specific inclusion and exclusion criteria for the study, replacing the previous placeholder text that indicated no information was provided.
    Difference
    13%
    Check dated 2024-05-22T20:59:18.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:29:03.000Z thumbnail image

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.